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Background: Exogenous administration of the anti-inflammatory cytokine, interleukin 10 (IL-10), is known to
promote neuroprotection and mitigate neuroinflammation after ischemia. However, endogenous expression and
localization of IL-10 and its receptor (IL-10R) in the post-ischemic brain are still to be elucidated. In this investigation
we aimed at determining the temporospatial expression of IL-10 in the rat brain relative to its systemic levels after
ischemic stroke.
Methods: Wistar rats were subjected to either permanent (pMCAO) or 3-h temporary (tMCAO) middle cerebral
artery occlusion and euthanized at either 24 or 72 h. IL-10/IL-10R levels were quantified in ischemic and contralesional
hemispheres and compared to shams using multiplex bead array and Western blotting, respectively. Localization of
IL-10/IL-10R with markers for neurons, microglia, astrocytes & endothelial cells were examined using double labeling
immunofluorescence. IL-10 was also quantified in the brain tissue of spontaneously hypertensive rats (SHRs) at 24 h
after tMCAO.
Results: After both pMCAO and tMCAO in Wistars, IL-10 was significantly upregulated in both hemispheres by ≈ 50%
at 24 h while IL-10R expression was significantly decreased only at 72 h in the ischemic hemisphere. IL-10 and IL-10R
expression highly co-localized with viable neurons in the ischemic penumbra and contralesional hemisphere. In
hypertensive rats, IL-10 showed no significant contralesional upregulation and declined significantly in the ischemic
side at 24 h post-ischemia.
Conclusion: Our data highlights the involvement of the ischemic and contralesional neurons in the endogenous
anti-inflammatory response after ischemic stroke through increased production of IL-10. This increase in IL-10 is
blunted in hypertensive animals and may contribute to worse outcomes.Introduction
Innate inflammatory response is a major component of
the pathophysiology of ischemic stroke [1,2]. While
preclinical studies have shown beneficial effects with
adopting an anti-inflammatory approach in the treatment
of ischemic stroke, results from clinical trials have been
disappointing with no benefit or even worsened outcome
in ischemic stroke patients after anti-inflammatory
intervention [3,4]. This can be partly explained by the lack* Correspondence: sfagan@gru.edu
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stated.of full understanding of the endogenous anti-inflammatory
response in the brain following ischemia.
Animal studies have confirmed the anticipated neuro-
protective role of the anti-inflammatory cytokine, inter-
leukin 10 (IL-10), in ischemic stroke. Administration of
exogenous IL-10 centrally and systemically decreases
the infarct size in rats after permanent focal ischemia
[5], while IL-10 knockout mice showed larger infarct
volume following middle cerebral artery occlusion [6].
Moreover, post-ischemic IL-10 gene transfer attenuated
brain infarction in rats subjected to focal and global
ischemia [7]. In in-vitro models, IL-10 protects murine
cortical and cerebellar neurons from excitotoxic damage
and oxygen glucose deprivation by activating survivalLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
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have been associated with increased risk of stroke [9].
However, IL-10 is increased in the serum and CSF ofFigure 1 Cytokines temporal profile in Wistar rat brains and sera afte
IL-10 upregulation by about 50% in both hemispheres at 24 h compared to b
hemisphere at 24 h then subsided at 72 h. (B) Serum cytokine levels showed
SEM. i = ischemic hemisphere (red), c = contralesional hemisphere (blue). Solid
different from the corresponding baseline values (p < 0.05), ψ significantly diff
correspond to sham manipulated animals.patients after ischemic stroke with conflicting reports on
its correlation with improved versus worsened outcome
[10-12]. It is likely that the ratio of inflammatory versusr MCAO. (A) Brain cytokine analysis using Bio-plex 200 showed significant
aseline. Inflammatory cytokines were strongly increased in the ischemic
an ongoing increase at 24 and 72 h. Values are presented as mean ±
line represents pMCAO, dashed line represents tMCAO. *, # Significantly
erent from the corresponding 24 h values (p < 0.05). Baseline values
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overall status in the acute stroke period.
Despite existing knowledge, the temporospatial ex-
pression and cellular sources of endogenous IL-10 and
its receptor following ischemic stroke are still not
known. In the current study, we aimed to elucidate
the expression and cellular sources of IL-10 and its








Figure 2 Immunofluorescent localization of IL-10 in Wistar rat brains
penumbra and contralesional cortical, striatal and hippocampal neurons wi
(CD68). IL-10 showed no co-localiztion with markers of astrocytes (GFAP) o
72 h brain sections showed similar pattern. N = 4 per group.post ischemia. In addition, we examined the change in
IL-10 levels after stroke in hypertensive rats.
Methods
Middle cerebral artery occlusion (MCAO)
All experimental procedures were approved by the
institutional Animal Care and Use Committee of the
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Figure 3 Temporal IL-10R expression in Wistar rat brains after
tMCAO. Western blotting analysis showed no change in IL-10Rɑ
protein expression in Wistars brains at 24 after tMCAO but it
declined significantly at 72 h relative to baseline. # significantly
different from the sham right hemisphere (p < 0.05), $ significantly
different from the 72 h time point contralesional hemisphere
(p < 0.05), N = 4-7 per group.
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(SHR) rats (270–320 g) underwent permanent (pMCAO)
(n = 9), 3 h-temporary (tMCAO) (n = 25) middle cerebral
artery occlusion using the suture model, or sham oper-
ation (n = 18) as described [13]. Animals were sacrificed at
24 or 72 h and brain tissues were collected for molecular
analysis and immunofluorescence.
Multiplex array system
Cytokine levels in brain homogenates and sera from
Wistar rats were simultaneously analyzed using a multiplex
array system (Bio-Plex 200; Bio-Rad) according to the
manufacturer instructions. After calibrating the instrument,
25 μg for brain and 50 μL of sera were run in triplicates
using 4-plex assay kits for tissue and sera respectively
and compared to serial dilutions of the standards provided
with the kits. Concentrations were determined using
the Bio-Plex Manager software program (Bio-Rad version
4.1.1). Cytokine levels below detection limit were assigned
a zero value.
Enzyme linked immunosorbent assay (ELISA)
Brain homogenates from spontaneously hypertensive rats
(SHRs) were analyzed for IL-10 using Rat IL-10 sandwich
ELISA (RayBiotech) according to the manufacturer’s
instructions.
Western blotting
Brain homogenate aliquots containing 50 μg protein were
separated on SDS-PAGE, transferred to nitrocellulose
membranes and probed with anti-IL-10Rα rabbit anti-
rat antibody (1:500, Santa Cruz) [13]. Protein bands
were quantified and normalized to β-actin using ImageJ
software.
Double-labelling immunofluorescence
4 μm paraffin embedded brain sections were processed
simultaneously. After rehydration, the sections were boiled
in sodium citrate buffer (pH 6.0) for antigen retrieval,
permeabilized and blocked in 10% horse serum with
1% BSA in TBS for 2 h at 25°C. For double labeling,
two primary antibodies were incubated simultaneously
overnight at 4°C at the following dilutions: rabbit anti-
IL-10 (1/100; invitrogen), rabbit anti-IL-10Rα (1/100;
Santa Cruz), mouse anti-neuronal nuclei (NeuN) (1/
100; Millipore) a marker for neurons, mouse anti-glial
fibrillary acidic protein (GFAP) (1/300; Sigma-Aldrich)
a marker for astrocytes, mouse anti-CD68 (1/100; AbD
Serotec) a marker for reactive microglia/macrophages,
and goat anti-Von Willebrand factor (VWF) (1/100; Santa
Cruz) a marker for endothelial cells. After washing,
slides were incubated with fluorescent secondary
antibodies, cover slipped with Vectashield mounting
medium (Vector Laboratories) and viewed using Zeis AxioObserver.Z1 fluorescent microscope. Negative controls
were prepared by omitting the primary antibodies.
Statistical analysis
The results are expressed as the means ± SEM, and
statistical analyses were performed with Student’s t-test
using NCSS 2007 software. P values less than 0.05 were
considered significant.
Results
IL-10 is upregulated in both hemispheres at 24 h after
MCAO in Wistars
We used the Multiplex array system (Bio-plex 200) to
study the cytokine temporal profile in brains and sera of
Wistar rats at subacute (24 h) and delayed (72 h) time
points in response to MCAO. IL-10 significantly increased
by about 50% in both hemispheres at 24 h after both
permanent and temporary MCAO. On the other hand,
inflammatory cytokines (IL-6, IL-1α & TNF-α) fold increase
was much higher in the lesional hemisphere at 24 h
with more upregulation after tMCAO then subsided at
72 h (Figure 1A). All cytokine serum levels were signifi-
cantly upregulated at 24 h and further increased by 2–3
fold at 72 h (Figure 1B).
Neurons are the main source of IL-10 after MCAO
Using double labeling immunofluorescence, we explored
the spatial expression of IL-10 in sham Wistar rat brains
and at 24/72 h after tMCAO using markers for neurons,
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showed strong co-localization with the neuronal marker,
NeuN, in the ischemic penumbra and contralesional
cortical, striatal and hippocampal neurons with less
expression in the ischemic core neurons or activated
microglia (CD68). IL-10 showed no co-localization with
markers of astrocytes (GFAP) or endothelial cells (VWF)
at the time points studied (Figure 2).
Temporal and spatial interleukin 10 receptor (IL-10R)
protein expression after tMCAO in Wistars
IL-10 executes its pleiotropic actions through binding
to IL-10 receptor complex that is composed of two








Figure 4 Immunofluorescent localization of IL-10R in Wistar rat brain
endothelial cells (VWF) of sham and stroked animals in addition to activate
(GFAP). Images were taken from 24 h brain sections. 72 h brain sections shsubunits, IL-10Rα is specific for the IL-10 signaling
pathway while IL-10Rβ is part of other cytokine receptor
complexes as well [14].
To test whether stroke modulates IL-10Rα expression,
we performed Western blotting and immunostaining
on Wistar brains subjected to tMCAO. IL-10Rα protein
expression did not change at 24 h after tMCAO relative
to baseline. However, it significantly declined in the
stroked hemisphere at 72 h (Figure 3). Immunfloures-
cent co-localization showed strong IL-10R expression
in the neurons (NeuN) and endothelial cells (VWF) of
sham operated animals and this expression was ex-
tended to activated microglia (CD68) after tMCAO




s after tMCAO. IL-10Rɑ strongly expressed in neurons (NeuN) and
d microglia/macrophages (CD68) after tMCAO but not astrocytes
owed similar results. N = 4 per group.
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after MCAO
Hypertension is associated with a pro-inflammatory
milieu. For this reason, we examined the IL-10 levels
in SHRs brains after sham operation and at 24 h after
3 h-tMCAO. Baseline IL-10 levels were less in hyper-
tensive rats compared to Wistars. After MCAO, IL-10
was significantly decreased in the stroked hemisphere
together with a slight increase in the contralesional
hemisphere that was not significant (Figure 5).Discussion
This study investigated the endogenous expression of
IL-10 and its receptor in the rat brain after experimental
stroke. We show, for the first time, that IL-10 is up-
regulated in both hemispheres at 24 h after both p- and
t-MCAO, in contrast to the inflammatory cytokines
that were upregulated on the ischemic side. Moreover,
immunostaining studies showed neurons to be the major
source of IL-10 and its receptor. IL-10 receptor was also
expressed in microglia & endothelial cells in accordance
with the literature [8,15]. Together with previous reports
of localization of IL-6 and its receptor with ischemic
brain neurons [16], our data highlights the involvement
of neurons in the ischemic inflammatory response being
both the source and target of cytokine actions.
The discrepancies in the cytokine levels between brain
and serum at 72 h point to the strong involvement of
the systemic immune response in cytokine production at
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Figure 5 IL-10 expression in SHR brains at 24 h after tMCAO. IL-
10 levels were quantified in brains of sham and stroked SHR using
ELISA. IL-10 was significantly decreased in the ischemic hemisphere
of SHRs with a slight non-significant increase contralesionally at 24 h
after tMCAO relative to sham values. N = 8 per group. * Significantly
different from the sham right hemisphere (p < 0.05), # significantly
different from the stroked hemisphere (p < 0.05), N = 8 per group.not necessarily reflect the local inflammation ongoing
in the brain.
Hypertension is a major risk factor for ischemic stroke.
The low baseline levels and loss of early upregulation
of IL-10 in spontaneously hypertensive rats (SHRs)
24 h after MCAO shows an impaired anti-inflammatory
response after ischemic stroke that might be associated
with the impaired recovery and worsened outcome in
these animals [17].
In summary, our study highlights the contribution of
the ischemic and contralesional neurons to the anti-
inflammatory response after ischemic stroke through
upregulation of IL-10. This outcome is lost under the
inflammatory milieu of hypertension. Taken together,
these findings suggest that endogenous IL-10 could be
a therapeutic target to reduce ischemic damage especially
under hypertension. Despite this, the study is limited to
the time points examined and does not rule out a possible
late role of IL-10 after 3 days post-ischemia involving
other brain cells. While a recent study has underscored
the functional protective role of IL-10 in ischemic stroke
through ameliorating brain inflammation [18], further
investigations are needed to examine the mechanisms
involved in IL-10 upregulation post-ischemia.
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